Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOP”

28 trials

Showing 20 of 28 results

Early research (Phase 1)Study completedNCT04829786
What this trial is testing

Study to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in Healthy Japanese and Non-Asian Subjects

Who this might be right for
FOP
Clementia Pharmaceuticals Inc. 18
Testing effectiveness (Phase 2)Study completedNCT02279095
What this trial is testing

An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 58
Not applicableLooking for participantsNCT06724562
What this trial is testing

An Observational Pre-post Study to Observe if the Off Label Use of Anti-IL1 Therapies, Such as Anakinra or Canakinumab, Can Block ACVR1-induced Flare Activity and Heterotopic Ossification in FOP

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
University of California, San Francisco 11
Not applicableLooking for participantsNCT06089616
What this trial is testing

Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Ipsen 100
Not applicableUnknownNCT02745158
What this trial is testing

The Fibrodysplasia Ossificans Progressiva (FOP) Connection Registry

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
The International FOP Association 800
Not applicableStudy completedNCT02066324
What this trial is testing

Urine Sample Collection From FOP Patients

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Novartis Pharmaceuticals 25
Not applicableStudy completedNCT06064656
What this trial is testing

A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
Regeneron Pharmaceuticals 131
Not applicableStudy completedNCT04665323
What this trial is testing

An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Ipsen 411
Large-scale testing (Phase 3)Study completedNCT03312634
What this trial is testing

An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 107
Early research (Phase 1)Study completedNCT05099445
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis

Who this might be right for
Renal ImpairmentHemodialysis
Incyte Corporation 48
Not applicableStudy completedNCT04165161
What this trial is testing

Performance Diagnosis of a Patent Foramen Ovale During Lung Transplantation Using Transesophageal Echocardiography

Who this might be right for
Lung Transplant; Complications
Hopital Foch 50
Not applicableStudy completedNCT02322255
What this trial is testing

A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 114
Testing effectiveness (Phase 2)Study completedNCT03188666
What this trial is testing

Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Regeneron Pharmaceuticals 44
Not applicableLooking for participantsNCT07357311
What this trial is testing

Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie

Who this might be right for
Lung CancerBreast Cancer
Institut Curie 200
Not applicableTemporarily Not AvailableNCT07301450
What this trial is testing

An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT05039515
What this trial is testing

Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 113
Large-scale testing (Phase 3)WithdrawnNCT04577820
What this trial is testing

Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodyplasia Ossificans Progressiva (FOP)Heterotopic Ossification (HO)
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02190747
What this trial is testing

An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT04307953
What this trial is testing

Saracatinib Trial TO Prevent FOP

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Amsterdam UMC, location VUmc 20
Early research (Phase 1)Study completedNCT04818398
What this trial is testing

Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Daiichi Sankyo Co., Ltd. 48
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation